What are the risks and side effects of starting TRT in your 30s?

Short answer Starting testosterone replacement therapy (TRT) in your 30s can improve symptoms of true hypogonadism (fatigue, low libido, low bone density), but it carries several important risks — most notably reduced fertility, testicular atrophy, increased red blood cell count (polycythemia), possible effects on mood and sleep, and uncertain cardiovascular and prostate risks. Before starting, you should have a full workup and a clear plan for monitoring and for fertility if you might want children.

Main risks and side effects

• Fertility and testicular function

  • TRT suppresses LH/FSH and usually lowers sperm production. This commonly causes testicular shrinkage and can render you infertile while on therapy. Recovery after stopping TRT may take months to over a year and is not guaranteed.
  • If you plan to father children, discuss fertility-preserving options (see options below) and consider sperm banking before starting.

• Hematologic (polycythemia)

  • TRT can raise hematocrit/hemoglobin, increasing blood viscosity and raising the risk of blood clots, stroke, and heart attack. Routine monitoring of hematocrit is required; therapy may need dose changes, therapeutic phlebotomy, or stopping.

• Cardiovascular risk

  • Evidence is mixed. Some studies show increased cardiovascular events in certain high-risk groups; others show neutral or beneficial effects. If you have heart disease or high cardiovascular risk factors, evaluate with your clinician before starting.

• Prostate

  • TRT can increase PSA and may unmask or accelerate prostate cancer in rare cases. It’s generally contraindicated if you have known prostate cancer; baseline PSA and digital rectal exam (as indicated) are recommended.

• Mood, behavior, and sleep

  • Some people experience mood swings, increased aggression or irritability; others have improved mood. TRT can worsen or unmask obstructive sleep apnea.

• Skin, hair, and breast changes

  • Acne, oily skin, hair loss or accelerated male-pattern baldness, and gynecomastia (enlarged breast tissue) can occur—partly due to conversion of testosterone to estrogen.

• Liver effects

  • Oral 17-alpha-alkylated androgens (older formulations) can be hepatotoxic; modern TRT (gels, injectables, undecanoate) has less liver risk. Still: monitor LFTs if indicated.

• Injection/site or formulation-specific issues

  • Injectable testosterone can cause fluctuations in mood/energy if levels peak and trough between injections. Certain long-acting formulations have rare but specific risks (e.g., Aveed injections have reported pulmonary oil microembolism in rare cases).

Other practical considerations

• If low testosterone is due to reversible causes (obesity, untreated sleep apnea, certain medications, heavy alcohol or opioid use), treating the underlying cause may restore levels without TRT.
• Long-term commitment: many men stay on TRT for years; consider cost, monitoring, and lifestyle implications.

Baseline evaluation and monitoring

• Baseline tests before starting: morning total testosterone (repeated), free testosterone if indicated, LH and FSH, prolactin, SHBG (if needed), CBC (hematocrit), PSA, lipid panel, metabolic panel, and sleep apnea screening if suspicious. If central cause suspected, consider pituitary MRI.
• Typical monitoring: recheck testosterone level, hematocrit, and symptoms about 3 months after start/dose change, then every 6–12 months; PSA and lipids periodically.

Fertility-preserving options (if you want children)

• Sperm banking: recommend considering cryopreservation before starting TRT.
• Medications that raise testosterone without suppressing spermatogenesis:
  • Human chorionic gonadotropin (hCG) injections (brands include Ovidrel [recombinant], Pregnyl) can maintain intratesticular testosterone and sperm production when used with or instead of TRT.
  • Selective estrogen receptor modulators (SERMs) such as clomiphene citrate (Clomid) can raise endogenous testosterone while preserving fertility in some men.
  • For difficult cases, referral to a reproductive urologist or fertility specialist is appropriate.

Formulations and some brand names (why choose)

• Topical gels: AndroGel, Testim — convenient, steady levels, but risk of transference to others (skin contact).
• Nasal: Natesto — less systemic skin transfer, multiple daily doses.
• Short-acting injectables (self-injection): testosterone cypionate or enanthate (generic; Depo-Testosterone is a brand) — inexpensive, but may cause peaks/troughs.
• Long-acting injectable: Aveed (testosterone undecanoate) — infrequent dosing but requires clinic administration and has rare specific risks.
• Oral undecanoate: Jatenzo — oral option with monitoring requirements.
• Subcutaneous pellets: Testopel — implanted pellets give long-term delivery; require minor procedure and removal if problems arise.
• Fertility-preserving meds: Clomid (clomiphene), hCG (Pregnyl, Ovidrel) — used under specialist guidance.

Where/how to get evaluated and monitored

• Best: see an endocrinologist or urologist experienced with male reproductive/endocrine health for a complete evaluation and individualized plan.
• If you prefer telehealth for convenience, services such as Hims or Roman offer TRT management but may offer more limited evaluation—ensure they do appropriate baseline testing and monitoring.
• Labs: LabCorp and Quest are common for the blood testing and monitoring.

When to be cautious or avoid TRT

• Known or suspected prostate or breast cancer.
• Uncontrolled heart failure or polycythemia at baseline.
• Active desire to conceive without fertility-sparing strategies.

What to discuss with your clinician

• Why your testosterone is low (two low morning levels required for diagnosis).
• All medications and substances you take (opioids, steroids, certain antidepressants can lower testosterone).
• Family planning intentions.
• Your cardiovascular risk profile and sleep apnea screening.
• A clear monitoring plan (tests and frequency), thresholds for dose changes, and plans for fertility preservation if needed.

Bottom line TRT can help men with true hypogonadism, but in your 30s the biggest practical harms are loss of fertility and potential long-term health risks that require careful evaluation and monitoring. Before starting: get a full hormonal workup, consider sperm banking if you might want kids, discuss fertility-preserving alternatives (hCG, clomiphene), and plan regular lab monitoring with an experienced clinician.

If you want, I can:

• List the exact baseline labs and a monitoring schedule you can print and take to a doctor.
• Describe fertility-preserving regimens in more detail.
• Suggest how to find a reproductive urologist or endocrinologist in your area.